{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:39:01Z","timestamp":1774978741554,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40292-022-00511-y","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T01:03:15Z","timestamp":1648170195000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Shady","family":"Habboush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Adel","family":"Sofy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Taher","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Cherfaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah Mohamed","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Taha","family":"Abdelsattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-0520","authenticated-orcid":false,"given":"Ahmed","family":"Elmoursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"issue":"9455","key":"511_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton MB, Reynolds K, Muntner P, Whelton PK, He, J et al. Articles Introduction Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(05)17741-1","journal-title":"Lancet."},{"key":"511_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31679-8","author":"MH Forouzanfar","year":"2016","unstructured":"Forouzanfar MH, Afshin A, Alexander LT, Biryukov S, Brauer M, Cercy K, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016. https:\/\/doi.org\/10.1016\/S0140-6736(16)31679-8.","journal-title":"Lancet"},{"key":"511_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002. https:\/\/doi.org\/10.1016\/S0140-6736(02)11911-8.","journal-title":"Lancet"},{"key":"511_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61299-9","author":"FH Messerli","year":"2007","unstructured":"Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007. https:\/\/doi.org\/10.1016\/S0140-6736(07)61299-9.","journal-title":"Lancet"},{"key":"511_CR5","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243060-00002","author":"Y Yoshida","year":"2015","unstructured":"Yoshida Y, Shibata H. Secondary hypertension. Nihon Rinsho. 2015. https:\/\/doi.org\/10.2165\/00003495-199243060-00002.","journal-title":"Nihon Rinsho"},{"key":"511_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000355","author":"GC Roush","year":"2014","unstructured":"Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchiaf P, et al. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in nine cohorts of 13844 patients with hypertension. J Hypertens. 2014. https:\/\/doi.org\/10.1097\/HJH.0000000000000355.","journal-title":"J Hypertens"},{"key":"511_CR7","doi-asserted-by":"publisher","unstructured":"Bunag R. Essential hypertension. xPharm: the comprehensive pharmacology reference. 2007. https:\/\/doi.org\/10.1016\/B978-008055232-3.60057-1.","DOI":"10.1016\/B978-008055232-3.60057-1"},{"key":"511_CR8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-55-1-1","author":"LF Arnolda","year":"1997","unstructured":"Arnolda LF, Llewellyn-Smith IJ, Minson JB. Essential hypertension. Curr Ther (Seaforth). 1997. https:\/\/doi.org\/10.7326\/0003-4819-55-1-1.","journal-title":"Curr Ther (Seaforth)"},{"key":"511_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.184182","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA J Am Med Assoc. 2013. https:\/\/doi.org\/10.1001\/jama.2013.184182.","journal-title":"JAMA J Am Med Assoc"},{"key":"511_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2010.02.005","author":"AH Gradman","year":"2010","unstructured":"Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens. 2010. https:\/\/doi.org\/10.1016\/j.jash.2010.02.005.","journal-title":"J Am Soc Hypertens"},{"key":"511_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","author":"SD Persell","year":"2011","unstructured":"Persell SD. Prevalence of resistant hypertension in the United States, 2003\u20132008. Hypertension. 2011. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.170308.","journal-title":"Hypertension"},{"key":"511_CR12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-1-200801010-00190","author":"R Kunz","year":"2008","unstructured":"Kunz R, Friedrich C, Wolbers M, Mann JFE. Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease. Ann Intern Med. 2008. https:\/\/doi.org\/10.7326\/0003-4819-148-1-200801010-00190.","journal-title":"Ann Intern Med"},{"issue":"10","key":"511_CR13","first-page":"39","volume":"68","author":"H Thacker","year":"2020","unstructured":"Thacker H, Reddy KMK, Sreenivasa Murthy L, Sawhney JPS, Chaudhary G, Shah S, et al. Blood-pressure lowering efficacy and safety of perindopril\/indapamide\/amlodipine single-pill combination in hypertensive patients: phase III trial in India. J Assoc Physicians India. 2020;68(10):39\u201343.","journal-title":"J Assoc Physicians India"},{"key":"511_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"key":"511_CR15","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions: cochrane book series. 2008.","DOI":"10.1002\/9780470712184"},{"key":"511_CR16","unstructured":"The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Guidelines. https:\/\/www.gradeworkinggroup.org\/. Accessed 15 Aug 2021."},{"key":"511_CR17","unstructured":"Green S, Higgins P. Julian T, Alderson P, Clarke M, Mulrow D C, Oxman DA. Cochrane handbook: cochrane reviews: Ch 8: assessing risk of bias in included studies. Cochrane handbook for: systematic reviews of interventions. 2011; pp 3\u201310."},{"key":"511_CR18","unstructured":"RevMan 5 | Cochrane Community [Internet]."},{"key":"511_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"Br Med J"},{"issue":"4","key":"511_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s12325-017-0511-1","volume":"34","author":"A Mazza","year":"2017","unstructured":"Mazza A, Lenti S, Schiavon L, Sacco AP, Dell\u2019Avvocata F, Rigatelli G, et al. Fixed-dose triple combination of antihypertensive drugs improves blood pressure control: from clinical trials to clinical practice. Adv Ther. 2017;34(4):975\u201385.","journal-title":"Adv Ther"},{"key":"511_CR21","doi-asserted-by":"publisher","unstructured":"Mazza A, Townsend DM, Schiavon L, Torin G, Lenti S, Rossetti C, et al. HHS Public Access. 2020. https:\/\/doi.org\/10.1016\/j.biopha.2019.109539.Long-term","DOI":"10.1016\/j.biopha.2019.109539.Long-term"},{"issue":"7","key":"511_CR22","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s12325-017-0572-1","volume":"34","author":"G \u00c1brah\u00e1m","year":"2017","unstructured":"\u00c1brah\u00e1m G, D\u00e9zsi CA. The antihypertensive efficacy of the triple fixed combination of perindopril, indapamide, and amlodipine: the results of the PETRA study. Adv Ther. 2017;34(7):1753\u201363.","journal-title":"Adv Ther"},{"issue":"4","key":"511_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40261-019-00761-0","volume":"39","author":"K Tsioufis","year":"2019","unstructured":"Tsioufis K, Douma S, Kallistratos MS, Manolis AJ. Effectiveness and adherence to treatment with perindopril\/indapamide\/amlodipine single-pill combination in a greek population with hypertension. Clin Drug Investig. 2019;39(4):385\u201393.","journal-title":"Clin Drug Investig"},{"issue":"7","key":"511_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/HJH.0000000000001359","volume":"35","author":"JJ Mourad","year":"2017","unstructured":"Mourad JJ, Amodeo C, De Champvallins M, Brzozowska-Villatte R, Asmar R. Blood pressure-lowering efficacy and safety of perindopril\/indapamide\/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial. J Hypertens. 2017;35(7):1481\u201395.","journal-title":"J Hypertens"},{"issue":"10","key":"511_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40261-014-0223-0","volume":"34","author":"D P\u00e1ll","year":"2014","unstructured":"P\u00e1ll D, Sz\u00e1nt\u00f3 I, Szab\u00f3 Z. Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR. Clin Drug Investig. 2014;34(10):701\u20138.","journal-title":"Clin Drug Investig"},{"key":"511_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01225-8","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016. https:\/\/doi.org\/10.1016\/S0140-6736(15)01225-8.","journal-title":"Lancet"},{"key":"511_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12015","author":"JM Neutel","year":"2013","unstructured":"Neutel JM, Smith DHG. Hypertension management: rationale for triple therapy based on mechanisms of action. Cardiovasc Ther. 2013. https:\/\/doi.org\/10.1111\/1755-5922.12015.","journal-title":"Cardiovasc Ther"},{"key":"511_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67186-3","author":"NR Poulter","year":"2005","unstructured":"Poulter NR, Wedel H, Dahl\u00f6f B, Sever PS, Beevers DG, Caulfield M, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005. https:\/\/doi.org\/10.1016\/S0140-6736(05)67186-3.","journal-title":"Lancet"},{"key":"511_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61303-8","author":"A Patel","year":"2007","unstructured":"Patel A. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007. https:\/\/doi.org\/10.1016\/S0140-6736(07)61303-8.","journal-title":"Lancet"},{"key":"511_CR30","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200118030-00001","author":"J Staessen","year":"2001","unstructured":"Staessen J, Bulpitt C, Swift C, Fletcher A, Tuomilehto J, Beckett N, et al. Hypertension in the very elderly trial (HYVET): protocol for the main trial. Drugs Aging. 2001. https:\/\/doi.org\/10.2165\/00002512-200118030-00001.","journal-title":"Drugs Aging"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-022-00511-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-022-00511-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-022-00511-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T11:42:50Z","timestamp":1651146170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-022-00511-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s40292-022-00511-y","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics statement is not applicable because this study is based exclusively on published literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}}]}}